Table 6.
Comparison of the prices of anti-diabetic medicines in Afghanistan and five countries (USD)
| # | Name of Medicines | Iran | Pakistan | India | Nigeria | Egypt |
|---|---|---|---|---|---|---|
| 1 | Metformin 500 | 0.0133 | 0.0108 | 0.048 | 0.11 | 0.0224 |
| 2 | Metformin 850 | 0 | 0.0129 | 0.0144 | 0.11 | 0.016 |
| 3 | Metformin 1000 | 0.0195 | 0.0324 | 0.078 | 0.1375 | 0.0384 |
| 4 | Sitagliptin 50 | 0.0473 | 0.0977 | 0.372 | 0.0786 | 0.1664 |
| 5 | Sitagliptin 100 | 0.0926 | 0.171 | 0.378 | 0.2359 | 0.2624 |
| 6 | Glimepiride 1 | 0.0222 | 0.0187 | 0.0481 | 0.0968 | 0.0211 |
| 7 | Glimepiride 2 | 0.0236 | 0.0288 | 0.0768 | 0.1474 | 0.0448 |
| 8 | Glimepiride 3 | 0.0251 | 0.045 | 0.0864 | 0.1562 | 0.0499 |
| 9 | Glimepiride 4 | 0.0265 | 0.0597 | 0.1296 | 0.2684 | 0.064 |
| 10 | Glibenclamide 5 | 0.0051 | 0.0075 | 0.06 | 0.0528 | 0.0115 |
| 11 | Empagliflozin 25 | 0.1906 | 0.2736 | 0.684 | 1.5675 | 0.2432 |
| 12 | Dapagliflozin 5 | 0.0377 | 0.0846 | 0.132 | 0.7865 | 0.112 |
| 13 | Dapagliflozin 10 | 0.0553 | 0.1224 | 0.138 | 0.8833 | 0.3084 |
| 14 | Empagliflozin + Metformin 5 mg/500 | 0.0740 | 0.0822 | 0.3576 | 0 | 0.1568 |
| 15 | Empagliflozin + Metformin 5/850 mg | 0 | 0.0601 | 0 | 0 | 0.1728 |
| 16 |
Pioglitazone+ Metformin 15/500 mg |
0.0142 | 0.0252 | 0.0972 | 0.1749 | 0.0432 |
| 17 |
Pioglitazone+ Metformin 15/850 mg |
0 | 0.04348 | 0 | 0.1881 | 0.0508 |
| 18 | Empagliflozin + Metformin 12.5/800 mg | 0 | 0.07405 | 0 | 0 | 0.2048 |
| 19 |
Glimepiride + Metformin 1/500 mg |
0 | 0.0432 | 0.15 | 0.143 | 0.0384 |
| 20 |
Glimepiride + Metformin 2/500 mg |
0 | 0.0442 | 0.156 | 0.154 | 0.048 |
| 21 | Sitagliptin + Metformin 50/500 mg | 0.0639 | 0.1004 | 0.342 | 0.1562 | 0.144 |
| 22 |
Sitagliptin + Metformin 50/1000 mg |
0.0697 | 0.1130 | 0.36 | 0.1573 | 0.2016 |
| 23 | Insulin NPH |
1.6583 (1000 IU/10ML) |
3.1572 (100IU/ML) | 1.02 (40IU/ML) | 7.59 (100IU/ML) | 1.76 (100IU/ML) |
| 24 | Insulin Regular |
1.6583 (1000 IU/10ML) |
2.106 (100IU/ML) | 1.02 (40IU/ML) | 7.59 (100IU/ML) | 1.76 (100IU/ML) |
| 25 | Insulin glargine |
2.5591 (300 IU/3ML) |
4.284 (300 IU/3ML) |
14.4 (300 U/3ML) |
8.558 (300 IU/3ML) |
4.64 (300 IU/3ML) |
| 26 | Insulin Aspart |
2.9622 (300 IU/3ML) |
4.32 (300 IU/3ML) |
9.48 (300 IU/3ML) |
7.975 (300 IU/3ML) |
3.392 (300 IU/3ML) |
| 27 | insulin mix |
2.5591 (300 IU/3ML) |
4.6296 (300 IU/3ML) |
8.16 (300 IU/3ML) |
7.975 (300 IU/3ML) |
4.08 (300 IU/3ML) |
| 28 |
Glibenclamide+ Metformin 5/500 mg |
0.0109 | 0.0136 | 0.06 | 0.1826 | 0.0512 |
| 29 | linagliptin 5 mg | 0.0523 | 0.0216 | 0.096 | 0.6721 | 0.3507 |
| 30 | Gliclazide 30 mg | 0.0212 | 0.0288 | 0.09 | 0.0935 | 0.0307 |
| 31 | Gliclazide 60 mg | 0.0276 | 0.0648 | 0.126 | 0.1039 | 0.0512 |
| 32 | Empagliflozin 10 mg | 0.1147 | 0.252 | 0.48 | 0.5874 | 0.16 |
| 33 |
Glibenclamide+ Metformin 2.5\500 |
0.0100 | 0.0108 | 0.0408 | 0.1628 | 0.0288 |